ArticleFrontiers in endocrinology2018

Improved Cardiovascular and Cardiometabolic Risk in Patients With Type 1 Diabetes and Autoimmune Polyglandular Syndrome Switched From Glargine to Degludec Due to Hypoglycaemic Variability.

Valentina Guarnotta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.